PHRD-628: Neoplastic Disorders

This Neoplastic Disorder Elective builds upon the PHRD-420 Pharmacotherapeutics VI - Immunologic, Hematologic, Rheumatologic & Neoplastic Disorders. Neoplastic disorders (oncology) encompass hundreds of various cancer types such that the PHRD-420 is actually an introduction to neoplastic disorders covering only four of the major cancers. The PHRD-420 provides the necessary foundation for this course and introduces all students to the field of oncology. For pharmacy students intending to work in an acute care hospital setting and especially those with an interest in specializing in oncology, this elective will set a solid foundation for such a practice by coverning additional major cancer types and focusing on the management of complications of cancers and chemo-biotherapy side effects. As with the PHRD-420 Pharmacotherapeutics VI, this elective course combines material from four major content areas: pathophysiology, pharmacology, medicinal chemistry, but with a major focus on therapeutics. This elective course is designed to provide students with the opportunity to learn, integrate and apply concepts from the four content areas in order to provide the necessary information for pharmaceutical management of neoplastic disease states and the complications thereof. Prerequisite: PHRD-420 Pharmacotherapeutics VI: Immunologic, Hematologic, Rheumatologic & Neoplastic Disorders. [ 2 credits ]